Galenica is a Swiss healthcare company headquartered in Bern, Switzerland. It was founded in 1927 and has since become a leading player in the healthcare industry, with a diverse range of products and services. Galenica operates through three main divisions: Retail, Products & Brands, and Services.

The Retail division includes the company's network of pharmacies, which operate under the brands Amavita, Sun Store, and Winconcept. These pharmacies offer a wide range of pharmaceutical products, personal care items, and health services. The Products & Brands division focuses on the development, production, and distribution of pharmaceutical products.

Galenica's portfolio includes prescription drugs, over-the-counter medications, dietary supplements, and medical devices. The company has a strong presence in Switzerland and also exports its products to various international markets. Galenica's Services division provides solutions and services to the healthcare sector.

This includes logistics, distribution, and marketing services for pharmaceutical products, as well as support services for pharmacies and healthcare professionals. Galenica has expanded its global reach through various subsidiaries, joint ventures, and partnerships. Notably, the company acquired Relypsa, a US-based biopharmaceutical company, in 2016.

This acquisition expanded Galenica's presence in the US market and strengthened its product portfolio. In terms of market position, Galenica is a key player in the Swiss healthcare industry and has a significant presence in international markets. The company has reported strong global sales in recent years, demonstrating its competitive position.

Galenica has achieved several significant milestones in its growth and development. In 2017, the company implemented a strategic transformation, rebranding itself as Vifor Pharma and focusing on the development and commercialization of innovative therapies in the field of nephrology. This strategic shift aims to drive future growth and enhance the company's global market position.

As of the latest updates, Galenica, now known as Vifor Pharma, continues to innovate and expand its product portfolio. The company remains committed to improving the lives of patients worldwide through its pharmaceutical products and services